Insulet [PODD] vs Medtronic plc [MDT] Detailed Stock Comparison

Insulet

NASDAQ
Loading...

Medtronic plc

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Insulet wins in 6 metrics, Medtronic plc wins in 13 metrics, with 0 ties. Medtronic plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricInsuletMedtronic plcBetter
P/E Ratio (TTM)94.2426.99Medtronic plc
Price-to-Book Ratio14.872.62Medtronic plc
Debt-to-Equity Ratio99.4959.44Medtronic plc
PEG Ratio-1.0716.70Insulet
EV/EBITDA45.9615.46Medtronic plc
Profit Margin (TTM)10.01%13.63%Medtronic plc
Operating Margin (TTM)18.66%18.69%Medtronic plc
EBITDA Margin (TTM)18.66%18.69%Medtronic plc
Return on Equity19.18%9.74%Insulet
Return on Assets (TTM)7.75%4.57%Insulet
Free Cash Flow (TTM)$296.30M$5.19BMedtronic plc
Dividend YieldN/A3.27%N/A
1-Year Return34.47%10.04%Insulet
Price-to-Sales Ratio (TTM)9.223.66Medtronic plc
Enterprise Value$22.09B$146.05BMedtronic plc
EV/Revenue Ratio9.364.27Medtronic plc
Gross Profit Margin (TTM)69.67%65.02%Insulet
Revenue per Share (TTM)$34$27Insulet
Earnings per Share (Diluted)$3.28$3.62Medtronic plc
Beta (Stock Volatility)1.400.79Medtronic plc
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Insulet vs Medtronic plc Stock Performance Analysis

Loading Price Chart...

Insulet
Medtronic plc
Insulet Stock Overview | Medtronic plc Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Insulet0.56%1.53%-10.33%4.24%22.33%22.04%
Medtronic plc-0.10%3.24%5.74%12.16%18.26%22.58%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Insulet34.47%41.76%26.22%914.07%1,872.62%1,964.89%
Medtronic plc10.04%20.49%-10.71%32.68%195.37%75.12%

News Based Sentiment: Insulet vs Medtronic plc

Insulet

News based Sentiment: MIXED

Insulet reported exceptional Q2 results and raised guidance, indicating strong growth. However, a Goldman Sachs price target cut and insider selling created market headwinds, resulting in a mixed investment narrative. The combination of positive financial performance and negative market reactions makes this a significant month for the company.

View Insulet News Sentiment Analysis

Medtronic plc

News based Sentiment: POSITIVE

Medtronic delivered a strong earnings report in August and continued positive momentum throughout October with product launches, share repurchases, and increased institutional investment. While some analyst downgrades exist, the overall narrative is one of solid performance and strategic advancement, making it a significant month for the company.

View Medtronic plc News Sentiment Analysis

Performance & Financial Health Analysis: Insulet vs Medtronic plc

MetricPODDMDT
Market Information
Market Cap i$22.61B$125.65B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i676,6507,625,170
90 Day Avg. Volume i637,9777,004,330
Last Close$313.45$98.33
52 Week Range$225.37 - $353.50$79.29 - $99.37
% from 52W High-11.33%-1.05%
All-Time High$353.50 (Sep 09, 2025)$135.89 (Sep 06, 2021)
% from All-Time High-11.33%-27.64%
Growth Metrics
Quarterly Revenue Growth0.33%0.08%
Quarterly Earnings Growth-0.88%0.00%
Financial Health
Profit Margin (TTM) i0.10%0.14%
Operating Margin (TTM) i0.19%0.19%
Return on Equity (TTM) i0.19%0.10%
Debt to Equity (MRQ) i99.4959.44
Cash & Liquidity
Book Value per Share (MRQ)$20.78$37.36
Cash per Share (MRQ)$15.93$6.33
Operating Cash Flow (TTM) i$516.20M$7.15B
Levered Free Cash Flow (TTM) i$112.66M$4.46B
Dividends
Last 12-Month Dividend Yield iN/A3.27%
Last 12-Month Dividend iN/A$2.80

Valuation & Enterprise Metrics Analysis: Insulet vs Medtronic plc

MetricPODDMDT
Price Ratios
P/E Ratio (TTM) i94.2426.99
Forward P/E i79.8716.70
PEG Ratio i-1.0716.70
Price to Sales (TTM) i9.223.66
Price to Book (MRQ) i14.872.62
Market Capitalization
Market Capitalization i$22.61B$125.65B
Enterprise Value i$22.09B$146.05B
Enterprise Value Metrics
Enterprise to Revenue i9.364.27
Enterprise to EBITDA i45.9615.46
Risk & Other Metrics
Beta i1.400.79
Book Value per Share (MRQ) i$20.78$37.36

Financial Statements Comparison: Insulet vs Medtronic plc

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PODDMDT
Revenue/Sales i$569.00M$8.58B
Cost of Goods Sold i$160.00M$3.00B
Gross Profit i$409.00M$5.58B
Research & Development i$59.60M$726.00M
Operating Income (EBIT) i$88.80M$1.52B
EBITDA i$118.50M$2.30B
Pre-Tax Income i$48.10M$1.30B
Income Tax i$12.70M$255.00M
Net Income (Profit) i$35.40M$1.05B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PODDMDT
Cash & Equivalents i$1.28B$2.22B
Total Current Assets i$2.33B$23.81B
Total Current Liabilities i$520.40M$12.88B
Long-Term Debt i$1.61B$25.64B
Total Shareholders Equity i$1.33B$48.26B
Retained Earnings i$75.70M$31.48B
Property, Plant & Equipment iN/A$7.16B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PODDMDT
Operating Cash Flow i$81.00M$2.14B
Capital Expenditures iN/A$-459.00M
Free Cash Flow i$48.10M$2.07B
Debt Repayment i$-182.70MN/A
Common Stock Repurchase iN/A$-274.00M

Short Interest & Institutional Ownership Analysis

MetricPODDMDT
Shares Short i1.50M12.79M
Short Ratio i2.751.78
Short % of Float i0.03%0.01%
Average Daily Volume (10 Day) i676,6507,625,170
Average Daily Volume (90 Day) i637,9777,004,330
Shares Outstanding i70.20M1.28B
Float Shares i70.08M1.28B
% Held by Insiders i0.00%0.00%
% Held by Institutions i1.02%0.87%

Dividend Analysis & Yield Comparison: Insulet vs Medtronic plc

MetricPODDMDT
Last 12-Month Dividend iN/A$2.80
Last 12-Month Dividend Yield iN/A3.27%
3-Year Avg Annual Dividend iN/A$2.76
3-Year Avg Dividend Yield iN/A0.83%
3-Year Total Dividends iN/A$8.28
Ex-Dividend DateN/AMar 28, 2025